Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
Prescription opioid use and cognitive function in older adults with chronic pain: A population-based longitudinal cohort study.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Wei Yu-Jung Jenny, Winterstein Almut G, Schmidt Siegfried, Fillingim Roger B, Schmidt Stephan, Daniels Michael J, DeKosky Steven T
Аннотация
INTRODUCTION: Whether prescription opioid exposure, duration, and dose are associated with cognitive function remains inconclusive.
METHODS: A longitudinal cohort among 3097 older adults with chronic pain and without dementia was conducted using Health and Retirement Study (HRS) linked to Medicare data from 2006 to 2020. Prescription opioid exposure, cumulative use for ≥ 90 days, and high-dose use (≥ 90 morphine milligram equivalents [MME] daily) were assessed biennially. Memory score and dementia probability were derived from HRS cognitive measures and analyzed using linear mixed-effects models.
RESULTS: Adjusted memory decline and dementia probability were not statistically different between patients with (vs. without) opioid exposure and between patients with cumulative use for ≥ 90 days (vs. < 90 days) but were higher between participants with high-dose opioid use (vs. low-dose) at the end of the follow-up.
DISCUSSION: Prescription opioid exposure and duration were not associated, but high-dose opioid use was associated with greater memory decline and dementia probability.
HIGHLIGHTS: Opioid use versus no use was not related to memory decline and dementia probability. Long-term opioid use was not related to memory decline and dementia probability. High-dose opioid use was related to greater memory decline and dementia probability.
METHODS: A longitudinal cohort among 3097 older adults with chronic pain and without dementia was conducted using Health and Retirement Study (HRS) linked to Medicare data from 2006 to 2020. Prescription opioid exposure, cumulative use for ≥ 90 days, and high-dose use (≥ 90 morphine milligram equivalents [MME] daily) were assessed biennially. Memory score and dementia probability were derived from HRS cognitive measures and analyzed using linear mixed-effects models.
RESULTS: Adjusted memory decline and dementia probability were not statistically different between patients with (vs. without) opioid exposure and between patients with cumulative use for ≥ 90 days (vs. < 90 days) but were higher between participants with high-dose opioid use (vs. low-dose) at the end of the follow-up.
DISCUSSION: Prescription opioid exposure and duration were not associated, but high-dose opioid use was associated with greater memory decline and dementia probability.
HIGHLIGHTS: Opioid use versus no use was not related to memory decline and dementia probability. Long-term opioid use was not related to memory decline and dementia probability. High-dose opioid use was related to greater memory decline and dementia probability.
Предметные рубрики MeSH
AgedAged, 80 and overFemaleHumansMaleMiddle AgedAging in PlaceAnalgesics, OpioidChronic PainCognitive AgingDementiaDose-Response Relationship, DrugFollow-Up StudiesLongitudinal StudiesMedicareMemoryNeuropsychological TestsPrescription DrugsRisk AssessmentSelf ReportSurveys and QuestionnairesTime FactorsUnited StatesCognition